Finding 1147277 (2023-004)

Significant Deficiency Repeat Finding
Requirement
ABCEHLM
Questioned Costs
-
Year
2023
Accepted
2025-07-09

AI Summary

  • Core Issue: Internal controls failed to record revenues and expenses accurately, leading to discrepancies in accrued vacation for 2023 and 2022.
  • Impacted Requirements: Compliance with Uniform Guidance is at risk, as grant expenditures may not align with the correct fiscal year.
  • Recommended Follow-Up: Hire additional accounting staff and establish month-end vacation accrual procedures to ensure timely and accurate financial reporting.

Finding Text

2023-004 Significant Deficiency - Accrued Vacation - Period of Performance Criteria: Uniform Guidance requires revenue to be recognized when federal expenditures under cost reimbursement contracts are incurred. Condition: The Organization's internal controls over financial reporting did not ensure that revenues and expenses were recorded in the proper period. Accrued vacation at June 30, 2023 and 2022 did not agree to the supporting detail resulting in adjustments that were not allocated to grants. Cause: This situation was attributed to the turnover and vacancy in the accounting department and the shortage of support staff. Effect: Grant expenditures and the associated invoicing for reimbursement do not occur in the appropriate fiscal year. Although this is just a timing difference, there is a potential to lose out on receiving reimbursement for expenses depending on the grant period. Questioned Costs: None Repeat Finding: Previously reported as finding 2022-007 Recommendation: Employ the necessary accounting personnel to ensure the financial statements are completed in an accurate and timely manner. Implement vacation accrual procedures at month end to ensure costs are captured in the appropriate period. Response: The Organization agrees with the finding. The Organization will implement a method to ensure accrued vacation is appropriately adjusted and vacation costs are accurately recorded and allocated to grants.

Categories

Cash Management Period of Performance Reporting Significant Deficiency Internal Control / Segregation of Duties

Other Findings in this Audit

  • 570816 2023-002
    Significant Deficiency Repeat
  • 570817 2023-002
    Significant Deficiency Repeat
  • 570818 2023-002
    Significant Deficiency Repeat
  • 570819 2023-002
    Significant Deficiency Repeat
  • 570820 2023-002
    Significant Deficiency Repeat
  • 570821 2023-002
    Significant Deficiency Repeat
  • 570822 2023-002
    Significant Deficiency Repeat
  • 570823 2023-002
    Significant Deficiency Repeat
  • 570824 2023-002
    Significant Deficiency Repeat
  • 570825 2023-003
    Significant Deficiency Repeat
  • 570826 2023-003
    Significant Deficiency Repeat
  • 570827 2023-003
    Significant Deficiency Repeat
  • 570828 2023-003
    Significant Deficiency Repeat
  • 570829 2023-003
    Significant Deficiency Repeat
  • 570830 2023-003
    Significant Deficiency Repeat
  • 570831 2023-003
    Significant Deficiency Repeat
  • 570832 2023-003
    Significant Deficiency Repeat
  • 570833 2023-003
    Significant Deficiency Repeat
  • 570834 2023-004
    Significant Deficiency Repeat
  • 570835 2023-004
    Significant Deficiency Repeat
  • 570836 2023-004
    Significant Deficiency Repeat
  • 570837 2023-004
    Significant Deficiency Repeat
  • 570838 2023-004
    Significant Deficiency Repeat
  • 570839 2023-004
    Significant Deficiency Repeat
  • 570840 2023-004
    Significant Deficiency Repeat
  • 570841 2023-004
    Significant Deficiency Repeat
  • 570842 2023-004
    Significant Deficiency Repeat
  • 1147258 2023-002
    Significant Deficiency Repeat
  • 1147259 2023-002
    Significant Deficiency Repeat
  • 1147260 2023-002
    Significant Deficiency Repeat
  • 1147261 2023-002
    Significant Deficiency Repeat
  • 1147262 2023-002
    Significant Deficiency Repeat
  • 1147263 2023-002
    Significant Deficiency Repeat
  • 1147264 2023-002
    Significant Deficiency Repeat
  • 1147265 2023-002
    Significant Deficiency Repeat
  • 1147266 2023-002
    Significant Deficiency Repeat
  • 1147267 2023-003
    Significant Deficiency Repeat
  • 1147268 2023-003
    Significant Deficiency Repeat
  • 1147269 2023-003
    Significant Deficiency Repeat
  • 1147270 2023-003
    Significant Deficiency Repeat
  • 1147271 2023-003
    Significant Deficiency Repeat
  • 1147272 2023-003
    Significant Deficiency Repeat
  • 1147273 2023-003
    Significant Deficiency Repeat
  • 1147274 2023-003
    Significant Deficiency Repeat
  • 1147275 2023-003
    Significant Deficiency Repeat
  • 1147276 2023-004
    Significant Deficiency Repeat
  • 1147278 2023-004
    Significant Deficiency Repeat
  • 1147279 2023-004
    Significant Deficiency Repeat
  • 1147280 2023-004
    Significant Deficiency Repeat
  • 1147281 2023-004
    Significant Deficiency Repeat
  • 1147282 2023-004
    Significant Deficiency Repeat
  • 1147283 2023-004
    Significant Deficiency Repeat
  • 1147284 2023-004
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $127,544
17.258 Wioa Adult Program $64,507
17.259 Wioa Youth Activities $57,368
17.278 Wioa Dislocated Worker Formula Grants $51,137
93.268 Immunization Cooperative Agreements $40,408
93.566 Refugee and Entrant Assistance State/replacement Designee Administered Programs $13,913
21.027 Coronavirus State and Local Fiscal Recovery Funds $11,805
93.596 Child Care Mandatory and Matching Funds of the Child Care and Development Fund $8,513
93.569 Community Services Block Grant $3,693
14.218 Community Development Block Grants/entitlement Grants $88